Alterations of the fragile histidine triad gene, FHIT, and its encoded products contribute to testicular germ cell tumorigenesis.
Sigrid Marie Kraggerud(Norwegian Cancer Society), Ragnhild A. Lothe(Oslo University Hospital), Pierre Åman(Acharya Narendra Deva University of Agriculture and Technology), Anna E. Stenwig(Norwegian Cancer Society), Jahn M. Nesland(Oslo University Hospital), Sophie D. Fosså(Oslo University Hospital), Ruth Holm(University of Aleppo)
PubMed
January 15, 2002
Cited by 18
Related Papers
5-Aminolevulinic acid-based photodynamic therapy
|Cancer|1997|976
Epigenetic and genetic features of 24 colon cancer cell lines
|Oncogenesis|2013|900
Endocrine treatment, with or without radiotherapy, in locally advanced prostate cancer (SPCG-7/SFUO-3): an open randomised phase III trial
|The Lancet|2008|873
Second Cancers Among 40 576 Testicular Cancer Patients: Focus on Long-term Survivors
|JNCI Journal of the National Cancer Institute|2005|830
Randomized Phase III Trial of High–Dose-Intensity Methotrexate, Vinblastine, Doxorubicin, and Cisplatin (MVAC) Chemotherapy and Recombinant Human Granulocyte Colony-Stimulating Factor Versus Classic MVAC in Advanced Urothelial Tract Tumors: European Organization for Research and Treatment of Cancer Protocol No. 30924
|Journal of Clinical Oncology|2001|628